JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 26:807-814
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sudhir, K
Right arrow Articles by Chatterjee, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sudhir, K
Right arrow Articles by Chatterjee, K

Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries

K Sudhir, TM Chou, WL Mullen, D Hausmann, P Collins, PG Yock, and K Chatterjee

Cardiovascular Research Institute, University of California at San Francisco, USA.

OBJECTIVES. We sought to examine the immediate vasodilator effect of intracoronary estrogen on epicardial and resistance coronary arteries in 19 dogs. BACKGROUND. Although estrogen reportedly dilates coronary arteries in vitro, the site and mechanisms of its action have not been fully defined in vivo. METHODS. Epicardial coronary artery dimensions and coronary flow velocity were assessed using simultaneous intracoronary two-dimensional and Doppler ultrasound. RESULTS. Estrogen (0.1 and 1 mumol/liter) induced a significant increase in coronary cross-sectional area, flow velocity and volumetric blood flow. Estrogen-induced vasodilation was not influenced either by pretreatment with N omega-nitro-L-arginine methyl ester (L-NAME) (100 mumol/liter intracoronary), indomethacin (5 mg/kg body weight intravenously), propranolol (0.75 mg/kg intravenously) or the classic estrogen receptor antagonist ICI 182,780 (10 mumol/liter). Balloon denudation of the endothelium did not attenuate estrogen-induced epicardial vasodilation. Pretreatment with glibenclamide (10 mumol/liter) attenuated estrogen-induced vasodilation only in epicardial arteries, as did verapamil (0.1 mumol/liter). Estrogen had no effect on a phenylephrine dose-response curve in either epicardial coronary arteries or the microcirculation. CONCLUSIONS. Acute estrogen-induced dilation in canine coronary arteries is endothelium independent and is not mediated by the classic intracellular estrogen receptor but through non-genomic mechanisms, presumably at the membrane level, which in epicardial arteries may include effects on adenosine triphosphate-sensitive potassium or calcium channels, or both.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P.-A. Scott, A. Tremblay, M. Brochu, and J. St-Louis
Vasorelaxant action of 17 -estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3713 - H3719.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. A. Parker, S. L. Smithmyer, J. A. Pelberg, A. D. Mishkin, M. D. Herr, and D. N. Proctor
Sex differences in leg vasodilation during graded knee extensor exercise in young adults
J Appl Physiol, November 1, 2007; 103(5): 1583 - 1591.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Traupe, C. D. Stettler, H. Li, E. Haas, I. Bhattacharya, R. Minotti, and M. Barton
Distinct Roles of Estrogen Receptors {alpha} and {beta} Mediating Acute Vasodilation of Epicardial Coronary Arteries
Hypertension, June 1, 2007; 49(6): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. R. Magness, T. M. Phernetton, T. C. Gibson, and D.-b. Chen
Uterine blood flow responses to ICI 182 780 in ovariectomized oestradiol-17{beta}-treated, intact follicular and pregnant sheep
J. Physiol., May 15, 2005; 565(1): 71 - 83.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Kipshidze, G. Dangas, M. Tsapenko, J. Moses, M. B. Leon, M. Kutryk, and P. Serruys
Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
L. W. Lissin, R. Oka, S. Lakshmi, and J. P Cooke
Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia
Vascular Medicine, February 1, 2004; 9(1): 26 - 30.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. Nishino, H.-J. Youn, D. Gheorghevici, C. Zellner, T. M. Chou, K. Sudhir, and R. F. Redberg
Effect of Intracoronary Estradiol on Postischemic Microvascular Damage in a Porcine Model: A Myocardial Contrast Echocardiographic Study
Angiology, November 1, 2003; 54(6): 701 - 709.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
K. L. Chambliss and P. W. Shaul
Estrogen Modulation of Endothelial Nitric Oxide Synthase
Endocr. Rev., October 1, 2002; 23(5): 665 - 686.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-H. Tsai, S.-F. Su, T.-F. Chou, and T.-M. Lee
Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17beta -Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Rouleau, A. Dagnault, D. Simard, B. Lavallee, A. Belanger, A. Blouin, and J. G. Kingma Jr.
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1407 - H1412.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. Kakucs, S. Varbiro, G. L. Nadasy, E. Monos, and B. Szekacs
Acute, Nongenomic Vasodilatory Action of Estradiol Is Attenuated by Chronic Estradiol Treatment
Experimental Biology and Medicine, June 1, 2001; 226(6): 538 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. A. Figtree, C. M. Webb, and P. Collins
Tamoxifen Acutely Relaxes Coronary Arteries by an Endothelium-, Nitric Oxide-, and Estrogen Receptor-Dependent Mechanism
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 519 - 523.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
S. E. Reis, R. Holubkov, J. B. Young, B. G. White, J. N. Cohn, and A. M. Feldman
Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 529 - 533.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. A. Figtree, H. Griffiths, Y.-Q. Lu, C. M. Webb, K. MacLeod, and P. Collins
Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1977 - 1985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Nekooeian and C. C. Y. Pang
Effects of estrogen on venous function in rats with chronic heart failure
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1941 - H1947.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
L. R. Peterson, M. Courtois, L. F. Peterson, M. R. Peterson, V. G. Dávila-Román, R. J. Spina, and B. Barzilai
Estrogen Increases Hyperemic Microvascular Blood Flow Velocity in Postmenopausal Women
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 174M - 179.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Huang, D. Sun, A. Koller, and G. Kaley
17{beta}-Estradiol Restores Endothelial Nitric Oxide Release to Shear Stress in Arterioles of Male Hypertensive Rats
Circulation, January 4, 2000; 101(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Sudhir and P. A. Komesaroff
Cardiovascular Actions of Estrogens in Men
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3411 - 3415.
[Full Text] [PDF]


Home page
CirculationHome page
G. A. Figtree, Y.-q. Lu, C. M. Webb, and P. Collins
Raloxifene Acutely Relaxes Rabbit Coronary Arteries In Vitro by an Estrogen Receptor–Dependent and Nitric Oxide–Dependent Mechanism
Circulation, September 7, 1999; 100(10): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
V M Miller
Gender and vascular reactivity
Lupus, June 1, 1999; 8(5): 409 - 415.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
H. Teoh, S. W.S. Leung, and R. Y.K. Man
Short-term exposure to physiological levels of 17{beta}-estradiol enhances endothelium-independent relaxation in porcine coronary artery
Cardiovasc Res, April 1, 1999; 42(1): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Christ, A. Gunther, M. Heck, B. M. W. Schmidt, E. Falkenstein, and M. Wehling
Aldosterone, Not Estradiol, Is the Physiological Agonist for Rapid Increases in cAMP in Vascular Smooth Muscle Cells
Circulation, March 23, 1999; 99(11): 1485 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zellner, A. A. Protter, E. Ko, M. R. Pothireddy, T. DeMarco, S. J. Hutchison, T. M. Chou, K. Chatterjee, and K. Sudhir
Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries
Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1049 - H1057.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Christ and M. Wehling
Cardiovascular steroid actions: swift swallows or sluggish snails?
Cardiovasc Res, October 1, 1998; 40(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. A. Komesaroff, C. V.S. Black, and R. A. Westerman
A Novel, Nongenomic Action of Estrogen on the Cardiovascular System
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2313 - 2316.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Nekooeian and C. C. Y. Pang
Estrogen restores role of basal nitric oxide in control of vascular tone in rats with chronic heart failure
Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H2094 - H2099.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Reis, V. Bhoopalam, K. A. Zell, P. J. Counihan, A. J. C. Smith, S. Pham, and S. Murali
Conjugated Estrogens Acutely Abolish Abnormal Cold-Induced Coronary Vasoconstriction in Male Cardiac Allografts
Circulation, January 13, 1998; 97(1): 23 - 25.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Sudhir, M. D. Esler, G. L. Jennings, and P. A. Komesaroff
Estrogen Supplementation Decreases Norepinephrine-Induced Vasoconstriction and Total Body Norepinephrine Spillover in Perimenopausal Women
Hypertension, December 1, 1997; 30(6): 1538 - 1543.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Sudhir, E. Ko, C. Zellner, H. E. Wong, S. J. Hutchison, T. M. Chou, and K. Chatterjee
Physiological Concentrations of Estradiol Attenuate Endothelin 1–Induced Coronary Vasoconstriction In Vivo
Circulation, November 18, 1997; 96(10): 3626 - 3632.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Sudhir, T. M. Chou, K. Chatterjee, E. P. Smith, T. C. Williams, J. P. Kane, M. J. Malloy, K. S. Korach, and G. M. Rubanyi
Premature Coronary Artery Disease Associated With a Disruptive Mutation in the Estrogen Receptor Gene in a Man
Circulation, November 18, 1997; 96(10): 3774 - 3777.
[Abstract] [Full Text]


Home page
CirculationHome page
V. Guetta, A. A. Quyyumi, A. Prasad, J. A. Panza, M. Waclawiw, and R. O. Cannon III
The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women
Circulation, November 4, 1997; 96(9): 2795 - 2801.
[Abstract] [Full Text]


Home page
CirculationHome page
G. M.C. Rosano, A. M. Caixeta, S. Chierchia, S. Arie, M. Lopez-Hidalgo, W. I. Pereira, F. Leonardo, C. M. Webb, F. Pileggi, and P. Collins
Short-term Anti-Ischemic Effect of 17ß-Estradiol in Postmenopausal Women With Coronary Artery Disease
Circulation, November 4, 1997; 96(9): 2837 - 2841.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Node, M. Kitakaze, H. Kosaka, T. Minamino, H. Funaya, and M. Hori
Amelioration of Ischemia- and Reperfusion-Induced Myocardial Injury by 17ß-Estradiol : Role of Nitric Oxide and Calcium-Activated Potassium Channels
Circulation, September 16, 1997; 96(6): 1953 - 1963.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. D. L. Fisher, C. Ferri, C. Bellini, A. Santucci, R. Gleason, G. H. Williams, N. K. Hollenberg, and E. W. Seely
Age, Gender, and Non-modulation : A Sexual Dimorphism in Essential Hypertension
Hypertension, April 1, 1997; 29(4): 980 - 985.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Oparil, R. L. Levine, S.-J. Chen, J. Durand, and Y.F. Chen
Sexually Dimorphic Response of the Balloon-Injured Rat Carotid Artery to Hormone Treatment
Circulation, March 4, 1997; 95(5): 1301 - 1307.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. L. Hale, Y. Birnbaum, and R. A. Kloner
Estradiol, Administered Acutely, Protects Ischemic Myocardium in Both Female and Male Rabbits
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 47 - 52.
[Abstract] [PDF]


Home page
CirculationHome page
T. M. Chou, K. Sudhir, S. J. Hutchison, E. Ko, T. M. Amidon, P. Collins, and K. Chatterjee
Testosterone Induces Dilation of Canine Coronary Conductance and Resistance Arteries In Vivo
Circulation, November 15, 1996; 94(10): 2614 - 2619.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Sudhir, G. L. Jennings, J. W. Funder, and P. A. Komesaroff
Estrogen Enhances Basal Nitric Oxide Release in the Forearm Vasculature in Perimenopausal Women
Hypertension, September 1, 1996; 28(3): 330 - 334.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.